Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038847 | SCV000062525 | likely benign | not specified | 2012-04-17 | criteria provided, single submitter | clinical testing | 208-15G>A in Intron 02 of ANKRD1: This variant is not expected to have clinical significance because it has been identified in 0.6% (24/3726) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs116511484). 208-15G>A in Intron 02 of AN KRD1 (allele frequency = 0.6%, 24/3726; dbSNP rs116511484) ** |
Gene |
RCV000038847 | SCV000166993 | benign | not specified | 2014-05-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV002054719 | SCV002406100 | benign | ANKRD1-related dilated cardiomyopathy | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000038847 | SCV005040613 | benign | not specified | 2024-03-28 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000038847 | SCV001919570 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000038847 | SCV001930842 | benign | not specified | no assertion criteria provided | clinical testing |